Associate Professor of Urology and Radiology
Icahn School of Medicine
Art Rastinehad, D.O. is currently an Associate Professor of Radiology; Associate Professor of Urology and the Director of Focal Therapy and Interventional Urologic Oncology at the Icahn School of Medicine at Mt. Sinai. Dr. Rastinehad trained at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship-trained in Urologic Oncology and Interventional Radiology.
Dr.Rastinehad has dedicated his career to research and education. His early research on Selective Arterial Prostatic Embolization (SAPE) for patients with refractory hematuria secondary to radiation prostatitis laid the foundation for his multidisciplinary approach, subsequently completing a urology residency and interventional radiology fellowship at North Shore LIJ in 2009. Dr. Rastinehad was then accepted into the Urologic Oncology and Image Guided Urology Fellowships at the National Institutes of Health. After his NIH fellowship, Dr. Rastinehad returned to NSLIJ start the first hybrid Interventional Urology Program and validate the seminal work from the NIH with respect to prostate imaging and MR/US fusion guided prostate biopsies. He has also authored and implemented clinical trials of new techniques in the diagnosis and treatment of localized prostate cancer.
MR US fusion guided prostate biopsy technique is helping to lay the foundation for the evaluation of Focal Therapy, which only treats the diseased portion of the prostate. As of May 2016, Dr.Rastinehad was the first in the world to perform a gold nano-particle directed ablation for localized prostate cancer. This was performed using a novel transperineal EM tracked MR US fusion biopsy system that was developed by Dr. Rastinehad and Drs. Pinto, Wood and Choyke from the NIH.
Thursday, October 31
5:00 PM – 6:00 PM
Friday, November 1
9:10 AM – 9:20 AM